FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-κB

Mi‐Jeong Kim(Ulsan College), Ki‐Young Lee(Samsung Medical Center)
Cell & Bioscience
June 7, 2023
Cited by 42


Related Papers